LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT04560972 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04560972
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2027-01-27
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.